Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05037591Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms), sponsored by UIN Sunan Kalijaga Yogyakarta. Primary endpoints: Peroxisome proliferator-activated receptor gamma coactivator 1-alpha at 4 weeks, Total Cholesterol at 4 weeks and 1 more. Started Aug 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05037591.